Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease

Name: Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease
Published: 2026
License: Public Domain

Société Algérienne de Formation et Recherche en Oncologie · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

algeria breast-cancer cancer real-world-data

breast cancer, her 2 positive breast cancer, algerian study, real-world data, algeria, biosimilar, pertuzumab, cancer, breast cancer in algerian patients, her2-positive breast cancer, neoadjuvant therapy, anti-her2 therapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 897713
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.